Xingmei Cao

157 Xiwu Road
Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study.

Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study.

Journal: Frontiers in oncology

Published: April 09, 2026

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts.

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts.

Journal: EJHaem

Published: February 26, 2026

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients.

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients.

Journal: Frontiers in oncology

Published: April 16, 2024

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia.

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia.

Journal: Journal of Cancer

Published: April 04, 2020

Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression.

Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression.

Journal: EXCLI journal

Published: July 29, 2019

Management of cytokine release syndrome related to CAR-T cell therapy.

Management of cytokine release syndrome related to CAR-T cell therapy.

Journal: Frontiers of medicine

Published: May 19, 2019

Regulation of expression of MLAA-34 gene through transcriptional factors E2F1 and MZF-1.

Regulation of expression of MLAA-34 gene through transcriptional factors E2F1 and MZF-1.

Journal: International journal of clinical and experimental pathology

Published: March 20, 2019

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Journal: Medicina clinica

Published: March 09, 2017

A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.

A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.

Journal: British journal of haematology

Published: December 04, 2016

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: November 16, 2016

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.

Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study.

Journal: OncoTargets and therapy

Published: July 07, 2016

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study.

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: May 28, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026